Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Carotuximab by Kairos Pharma for Non-Small Cell Lung Cancer: Likelihood of Approval
Carotuximab is under clinical development by Kairos Pharma and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Data Insights
Carotuximab by Kairos Pharma for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
Carotuximab is under clinical development by Kairos Pharma and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...